Summary
This prediction ended on 12.09.12 with a price of €127.68. With a performance of 8.66%, the BUY prediction by melinda for Carmat closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Carmat | - | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
According to melinda what are the pros and cons of Carmat for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Carmat diskutieren
künstliches Herz
CARMAT ist die Medizintechnik Start-up, wenn das Herz voll implantierbaren Herzunterstützungssystem oder eine Transplantation fehlgeschlagen oder nicht möglich sind (wie auf seine Dreharbeiten Fenster)
(Vom Mitglied beendet)